Etiopathogenesis of benign prostatic hypeprlasia
- PMID: 19881121
- PMCID: PMC2779950
- DOI: 10.4103/0970-1591.56179
Etiopathogenesis of benign prostatic hypeprlasia
Abstract
Benign prostatic hyperplasia (BPH) is the most common condition affecting men older than 50 years of age. It affects about 10 percent of men under the age of 40, and increases to about 80 percent by 80 years of age. BPH is a hyperplastic process of the fibromuscular stromal and glandular epithelial elements of the prostate. Aging and the presence of the functional testes are the two established risk factors for the development of BPH. The etiopathogenesis of BPH is still largely unresolved, but multiple partially overlapping and complementary theories have been proposed, all of which seem to be operative at least to some extent. This review is focused on recent progress in this area and on the growing consensus for the important mechanisms underlying the etiology and pathogenesis of BPH.
Conflict of interest statement
References
-
- Shabbir M, Mumtaz FH. Benign prostatic hyperplasia. J R Soc Health. 2004;124:222–7. - PubMed
-
- Lee C. Role of androgen in prostate growth and regression: Stromal-epithelial interaction. Prostate Suppl. 1996;6:52–6. - PubMed
-
- Coffey DS. The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED, editors. Campbella's Urology. 6th ed. Philadelphia: WB Saunders; 1992. pp. 221–301.
-
- Grayhack JT. Changes with aging in human seminal vesicle fluid fructose concentration and seminal vesicle weight. J Urol. 1961;86:142–8. - PubMed
-
- Cunha G, Wang YZ, Hayward SW, Risbridger GP. Estrogenic effects on prostatic differentiation and carcinogenesis. Reprod Fertil Dev. 2001;13:285–96. - PubMed
